Login to Your Account

Circassia Seeks Backers for Phase III Study of Allergy Therapy

By Nuala Moran
Staff Writer

Monday, September 16, 2013
LONDON – Circassia Ltd. is looking for shareholders’ backing for a Phase III trial of its house dust mite allergy treatment after reporting positive results in a Phase II study, with subjects who received the most effective dose showing a significant reduction in symptoms of allergic rhinitis at one year.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription